Canada Pension Plan Investment Board’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $3.93M | Sell |
|
|||||
|
2025
Q1 | $21.2M | Buy |
|
|||||
|
2024
Q4 | $4.65M | Sell |
|
|||||
|
2024
Q3 | $5.85M | Sell |
|
|||||
|
2024
Q2 | $9.15M | Sell |
|
|||||
|
2024
Q1 | $26M | Buy |
|
|||||
|
2023
Q4 | $8.68M | Buy |
|
|||||
|
2023
Q3 | $6.42M | Sell |
|
|||||
|
2023
Q2 | $9.24M | Buy |
|
|||||
|
2023
Q1 | $8.17M | Buy |
|
|||||
|
2022
Q4 | $7.67M | Buy |
|
|||||
|
2022
Q3 | $1.24M | Buy |
|
|||||
|
2022
Q2 | $331K | Sell |
|
|||||
|
2022
Q1 | $366K | Sell |
|
|||||
|
2021
Q4 | $2.13M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.74M | Buy |
|
|||||
|
2020
Q4 | $752K | Buy |
|
|||||
|
2020
Q3 | $177K | Sell |
|
|||||
|
2020
Q2 | $2.25M | Sell |
|
|||||
|
2020
Q1 | $1.88M | Buy |
|
|||||
|
2019
Q4 | $2.22M | Sell |
|
|||||
|
2019
Q3 | $2.3M | Sell |
|
|||||
|
2019
Q2 | $6.8M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.18M | Sell |
|
|||||
|
2017
Q2 | $1.14M | Buy |
|
|||||
|
2017
Q1 | $714K | Buy |
|
|||||
|
2016
Q4 | $453K | Buy |
|
|||||
|
2016
Q3 | $471K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $697K | Sell |
|
|||||
|
2015
Q4 | $3.87M | Buy |
|
|||||
|
2015
Q3 | $2.27M | Buy |
|